Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine the local (cervico-vaginal) and systemic (whole body) safety of vaginal immunisation with CN54gp140 glycoprotein administered 9 times over a 3 week period.
Inclusion criteria
- HIV Infections,Acquired Immune Deficiency Syndrome